scholarly journals Patents on Endophytic Fungi Related to Secondary Metabolites and Biotransformation Applications

2020 ◽  
Vol 6 (2) ◽  
pp. 58 ◽  
Author(s):  
Daniel Torres-Mendoza ◽  
Humberto E. Ortega ◽  
Luis Cubilla-Rios
Keyword(s):  
Biological Activity ◽  
Abiotic Stress ◽  
Secondary Metabolites ◽  
Secondary Metabolite ◽  
Endophytic Fungi ◽  
Wide Spectrum ◽  
Alternative Source ◽  
Metabolite Production ◽  
Mammalian Herbivores ◽  
Important Group

Endophytic fungi are an important group of microorganisms and one of the least studied. They enhance their host’s resistance against abiotic stress, disease, insects, pathogens and mammalian herbivores by producing secondary metabolites with a wide spectrum of biological activity. Therefore, they could be an alternative source of secondary metabolites for applications in medicine, pharmacy and agriculture. In this review, we analyzed patents related to the production of secondary metabolites and biotransformation processes through endophytic fungi and their fields of application. We examined 245 patents (224 related to secondary metabolite production and 21 for biotransformation). The most patented fungi in the development of these applications belong to the Aspergillus, Fusarium, Trichoderma, Penicillium, and Phomopsis genera and cover uses in the biomedicine, agriculture, food, and biotechnology industries.

scholarly journals Urgensi dan Mekanisme Biosintesis Metabolit Sekunder Mikroba Laut

2012 ◽  
Vol 10 (2) ◽  
pp. 120 ◽  
Author(s):  
Risa Nofiani
Keyword(s):  
Secondary Metabolites ◽  
Secondary Metabolite ◽  
Metabolic Pathways ◽  
Abiotic Factors ◽  
Biologically Active ◽  
Secondary Metabolite Production ◽  
Marine Microorganism ◽  
Metabolite Production ◽  
Biotic And Abiotic Factors ◽  
Living Materials

Marine microorganism is one of biologically active potential resources of secondary metabolites. Its potency areso promising that the knowledge of how its secondary metabolite occured need to be studied and collected. Thoseknowledges will enable further study is improving secondary metabolite production in the laboratory. In nature,secondary metabolites synthesis occur when there are effect of both biotic and abiotic factors such as sea waterand microbe symbiosis with other living materials. When this is explained in metabolic pathways, secondarymetabolite synthesis affected by available nutrient and regulated by autoinducer molecules through quorum sensingmechanism

scholarly journals Phylogenetic Distribution of Secondary Metabolites in the Bacillus subtilis Species Complex

mSystems ◽  
2021 ◽  
Vol 6 (2) ◽  
Author(s):  
Kat Steinke ◽  
Omkar S. Mohite ◽  
Tilmann Weber ◽  
Ákos T. Kovács
Keyword(s):  
Bacillus Subtilis ◽  
Secondary Metabolites ◽  
Secondary Metabolite ◽  
Species Complex ◽  
Gene Clusters ◽  
Biosynthetic Gene ◽  
Biosynthetic Gene Clusters ◽  
Content Type ◽  
Frameshift Mutations ◽  
Metabolite Production

ABSTRACT Microbes produce a plethora of secondary (or specialized) metabolites that, although not essential for primary metabolism, benefit them to survive in the environment, communicate, and influence cell differentiation. Biosynthetic gene clusters (BGCs), responsible for the production of these secondary metabolites, are readily identifiable on bacterial genome sequences. Understanding the phylogeny and distribution of BGCs helps us to predict the natural product synthesis ability of new isolates. Here, we examined 310 genomes from the Bacillus subtilis group, determined the inter- and intraspecies patterns of absence/presence for all BGCs, and assigned them to defined gene cluster families (GCFs). This allowed us to establish patterns in the distribution of both known and unknown products. Further, we analyzed variations in the BGC structures of particular families encoding natural products, such as plipastatin, fengycin, iturin, mycosubtilin, and bacillomycin. Our detailed analysis revealed multiple GCFs that are species or clade specific and a few others that are scattered within or between species, which will guide exploration of the chemodiversity within the B. subtilis group. Surprisingly, we discovered that partial deletion of BGCs and frameshift mutations in selected biosynthetic genes are conserved within phylogenetically related isolates, although isolated from around the globe. Our results highlight the importance of detailed genomic analysis of BGCs and the remarkable phylogenetically conserved erosion of secondary metabolite biosynthetic potential in the B. subtilis group. IMPORTANCE Members of the B. subtilis species complex are commonly recognized producers of secondary metabolites, among those, the production of antifungals, which makes them promising biocontrol strains. While there are studies examining the distribution of well-known secondary metabolites in Bacilli, intraspecies clade-specific distribution has not been systematically reported for the B. subtilis group. Here, we report the complete biosynthetic potential within the B. subtilis group to explore the distribution of the biosynthetic gene clusters and to reveal an exhaustive phylogenetic conservation of secondary metabolite production within Bacillus that supports the chemodiversity within this species complex. We identify that certain gene clusters acquired deletions of genes and particular frameshift mutations, rendering them inactive for secondary metabolite biosynthesis, a conserved genetic trait within phylogenetically conserved clades of certain species. The overview guides the assignment of the secondary metabolite production potential of newly isolated Bacillus strains based on genome sequence and phylogenetic relatedness.

scholarly journals Plant Secondary Metabolites Produced in Response to Abiotic Stresses Has Potential Application in Pharmaceutical Product Development

Molecules ◽  
2022 ◽  
Vol 27 (1) ◽  
pp. 313
Author(s):  
Karma Yeshi ◽  
Darren Crayn ◽  
Edita Ritmejerytė ◽  
Phurpa Wangchuk
Keyword(s):  
Abiotic Stress ◽  
Drug Discovery ◽  
Medicinal Plants ◽  
Secondary Metabolites ◽  
Natural Habitat ◽  
Plant Secondary Metabolites ◽  
Sample Collection ◽  
Pharmacological Activities ◽  
Alternative Source ◽  
Pharmaceutical Industries

Plant secondary metabolites (PSMs) are vital for human health and constitute the skeletal framework of many pharmaceutical drugs. Indeed, more than 25% of the existing drugs belong to PSMs. One of the continuing challenges for drug discovery and pharmaceutical industries is gaining access to natural products, including medicinal plants. This bottleneck is heightened for endangered species prohibited for large sample collection, even if they show biological hits. While cultivating the pharmaceutically interesting plant species may be a solution, it is not always possible to grow the organism outside its natural habitat. Plants affected by abiotic stress present a potential alternative source for drug discovery. In order to overcome abiotic environmental stressors, plants may mount a defense response by producing a diversity of PSMs to avoid cells and tissue damage. Plants either synthesize new chemicals or increase the concentration (in most instances) of existing chemicals, including the prominent bioactive lead compounds morphine, camptothecin, catharanthine, epicatechin-3-gallate (EGCG), quercetin, resveratrol, and kaempferol. Most PSMs produced under various abiotic stress conditions are plant defense chemicals and are functionally anti-inflammatory and antioxidative. The major PSM groups are terpenoids, followed by alkaloids and phenolic compounds. We have searched the literature on plants affected by abiotic stress (primarily studied in the simulated growth conditions) and their PSMs (including pharmacological activities) from PubMed, Scopus, MEDLINE Ovid, Google Scholar, Databases, and journal websites. We used search keywords: “stress-affected plants,” “plant secondary metabolites, “abiotic stress,” “climatic influence,” “pharmacological activities,” “bioactive compounds,” “drug discovery,” and “medicinal plants” and retrieved published literature between 1973 to 2021. This review provides an overview of variation in bioactive phytochemical production in plants under various abiotic stress and their potential in the biodiscovery of therapeutic drugs. We excluded studies on the effects of biotic stress on PSMs.

scholarly journals Unlocking Pharmacological and Therapeutic Potential of Hyacinth Bean (Lablab purpureus L.): Role of OMICS Based Biology, Biotic and Abiotic Elicitors

2021 ◽  
Author(s):  
Krishna Kumar Rai ◽  
Nagendra Rai ◽  
Shashi Pandey-Rai
Keyword(s):  
Secondary Metabolites ◽  
Secondary Metabolite ◽  
Molecular Mechanisms ◽  
Therapeutic Potential ◽  
Secondary Metabolite Production ◽  
Metabolite Production ◽  
Genetic Potential ◽  
Abiotic Elicitors ◽  
Hyacinth Bean ◽  
Underutilised Crops

Hyacinth bean also known as Indian bean is multipurpose legume crops consumed both as food by humans and as forage by animals. Being a rich source of protein, it also produces distinct secondary metabolites such as flavonoids, phenols and tyrosinase which not only help strengthened plant’s own innate immunity against abiotic/biotrophic attackers but also play important therapeutic role in the treatment of various chronic diseases. However, despite its immense therapeutic and nutritional attributes in strengthening food, nutrition and therapeutic security in many developing countries, it is still considered as an “orphan crop” for unravelling its genetic potential and underlying molecular mechanisms for enhancing secondary metabolite production. Several lines of literatures have well documented the use of OMICS based techniques and biotic and abiotic elicitors for stimulating secondary metabolite production particularly in model as well as in few economically important crops. However, only limited reports have described their application for stimulating secondary metabolite production in underutilised crops. Therefore, the present chapter will decipher different dimensions of multi-omics tools and their integration with other conventional techniques (biotic and abiotic elicitors) for unlocking hidden genetic potential of hyacinth bean for elevating the production of secondary metabolites having pharmaceutical and therapeutic application. Additionally, the study will also provide valuable insights about how these advance OMICS tools can be successfully exploited for accelerating functional genomics and breeding research for unravelling their hidden pharmaceutical and therapeutic potential thereby ensuring food and therapeutic security for the betterment of mankind.

scholarly journals Isolation and identification of endophytic fungi from mandarin orange (Citrus reticulata L.)

2022 ◽  
Vol 951 (1) ◽  
pp. 012052
Author(s):  
H Oktarina ◽  
D R Adithia ◽  
T Chamzurni
Keyword(s):  
Abiotic Stress ◽  
Secondary Metabolites ◽  
Endophytic Fungi ◽  
Morphological Characteristic ◽  
Plant Disease ◽  
Potato Dextrose Agar ◽  
Citrus Reticulata ◽  
Biotic And Abiotic Stress ◽  
Isolation And Identification ◽  
Mandarin Orange

Abstract Endophytic fungi are recognised for producing secondary metabolites that have an effect on the host, such as promoting growth and enhancing plant resilience to biotic and abiotic stress. The objective of this study was to explore endophytic fungi from Citrus reticulata. The endophytic fungi were isolated from both healthy and infected roots, stems, and twigs of C. reticulata. The materials were sterilised and inoculated on potato dextrose agar (PDA) media. The fungi grown were transferred onto fresh PDA plates and identified based on their morphological characteristic, including colonial features, hyphae type, and reproduction structure. Five endophytic fungi were identified as Colletotrichum sp. AJSH2-1, Cylindrocladium sp. BJSH1-2, Rhizopus sp. RJSH1-1, Mucor sp. RJSH1-2, and Aspergillus sp. BJSH1-1. Further study is required to understand the ability of the identified genera in protecting the host from plant disease as well as promoting growth.

scholarly journals Cleaning the Cellular Factory–Deletion of McrA in Aspergillus oryzae NSAR1 and the Generation of a Novel Kojic Acid Deficient Strain for Cleaner Heterologous Production of Secondary Metabolites

2021 ◽  
Vol 2 ◽  
Author(s):  
Trong T. Dao ◽  
Kate M. J. de Mattos-Shipley ◽  
Ian M. Prosser ◽  
Katherine Williams ◽  
Marija K. Zacharova ◽  
...  
Keyword(s):  
Secondary Metabolites ◽  
Natural Product ◽  
Secondary Metabolite ◽  
Aspergillus Oryzae ◽  
Kojic Acid ◽  
Negative Regulator ◽  
Secondary Metabolite Production ◽  
Phenotypic Change ◽  
Metabolite Production ◽  
Host Strains

The use of filamentous fungi as cellular factories, where natural product pathways can be refactored and expressed in a host strain, continues to aid the field of natural product discovery. Much work has been done to develop host strains which are genetically tractable, and for which there are multiple selectable markers and controllable expression systems. To fully exploit these strains, it is beneficial to understand their natural metabolic capabilities, as such knowledge can rule out host metabolites from analysis of transgenic lines and highlight any potential interplay between endogenous and exogenous pathways. Additionally, once identified, the deletion of secondary metabolite pathways from host strains can simplify the detection and purification of heterologous compounds. To this end, secondary metabolite production in Aspergillus oryzae strain NSAR1 has been investigated via the deletion of the newly discovered negative regulator of secondary metabolism, mcrA (multicluster regulator A). In all ascomycetes previously studied mcrA deletion led to an increase in secondary metabolite production. Surprisingly, the only detectable phenotypic change in NSAR1 was a doubling in the yields of kojic acid, with no novel secondary metabolites produced. This supports the previous claim that secondary metabolite production has been repressed in A. oryzae and demonstrates that such repression is not McrA-mediated. Strain NSAR1 was then modified by employing CRISPR-Cas9 technology to disrupt the production of kojic acid, generating the novel strain NSARΔK, which combines the various beneficial traits of NSAR1 with a uniquely clean secondary metabolite background.

scholarly journals Sekonder Bitki Metabolitlerinin In Vitro Koşullarda Üretimi

2019 ◽  
Vol 7 (7) ◽  
pp. 971
Author(s):  
Tuncay Çalışkan ◽  
Rüştü Hatipoğlu ◽  
Saliha Kırıcı
Keyword(s):  
Secondary Metabolites ◽  
Secondary Metabolite ◽  
Plant Cell ◽  
Abiotic Factors ◽  
Food Additives ◽  
Plant Secondary Metabolites ◽  
Secondary Metabolite Production ◽  
Organ Cultures ◽  
Metabolite Production

Plant secondary metabolites are a group of organic compounds produced by plants to interact with biotic and abiotic factors and for the establishment of defence mechanism. Secondary metabolites are classified based on their biosynthetic origin and chemical structure. They have been used as pharmaceutical, agrochemical, flavours, fragrances, colours and food additives. Secondary metabolites are traditionally produced from the native grown or field grown plants. However, this conventional approach has some disadvantages such as low yield, instability of secondary metabolite contents of the plants due to geographical, seasonal and environmental variations, need for land and heavy labour to grow plants. Therefore, plant cell and organ cultures have emerged as an alternative to plant growing under field conditions for secondary metabolite production. In this literature review, present state of secondary metabolite production through plant cell and organ cultures, its problems as well as solutions of the problems were discussed.

scholarly journals Secondary Metabolite Production by the Basidiomycete, Lentinus strigellus, under Different Culture Conditions

2012 ◽  
Vol 7 (6) ◽  
pp. 1934578X1200700 ◽  
Author(s):  
Bartholomeu A. Barros-Filho ◽  
Maria C. F. de Oliveira ◽  
Jair Mafezoli ◽  
Francisco G. Barbosa ◽  
Edson Rodrigues-Filho
Keyword(s):  
Secondary Metabolites ◽  
Liquid Medium ◽  
Secondary Metabolite ◽  
Culture Media ◽  
Indole Alkaloid ◽  
Culture Conditions ◽  
Secondary Metabolite Production ◽  
Metabolite Production ◽  
Czapek Medium

The basidiomycete Lentinus strigellus was cultivated in three different culture media and the secondary metabolites produced under different culture conditions were isolated and identified. When cultivated in a liquid medium with peptone, L. strigellus afforded the benzopyrans, 2,2-dimethyl-6-methoxychroman-4-one, 4-hydroxy-2,2-dimethyl-6-methoxychromane and (3 R,4 S)-3,4-dihydroxy-2,2-dimethyl-6-methoxychromane. The indole alkaloid echinuline and the anthraquinone fiscione, both unprecedented for the genus Lentinus, were isolated from the mycelium of the fungus. When cultured in Czapek medium enriched with potato broth, the fungus afforded the same benzopyrans except (3 S,4 S)-3,4-dihydroxy-2,2-dimethyl-6-methoxychromane. Panepoxydone and isopanepoxydone were also isolated when the microorganism was grown in Czapek medium.

Secondary Metabolite Produced by Diaporthe terebinthifolli LGMF658 – Bioactivity and Chemical Structure Relationship

2020 ◽  
Vol 16 (7) ◽  
pp. 1103-1107
Author(s):  
Fabiana Tonial ◽  
Charise D. Bertol ◽  
Beatriz H.L.N. Sales Maia ◽  
Josiane A.G. Figueiredo ◽  
Kielli C.F. Guerra ◽  
...  
Keyword(s):  
Biological Activity ◽  
Secondary Metabolites ◽  
Secondary Metabolite ◽  
Chemical Structure ◽  
Fungistatic Activity ◽  
Significant Difference ◽  
Structure Relationship ◽  
Bioactive Secondary Metabolite ◽  
Drug Studies ◽  
Diffusion Assay

Background: Motivated by the need for bioprospecting new drug studies have revealed a variety of secondary metabolites with biological activity. In particular, antimicrobial research confronts the growing reality of resistance of microorganisms to currently available drugs. Modifications in the chemical structure of secondary metabolites may be important in the development of a product to improve the efficacy of these compounds. Being cognizant of the fact that modifications in the chemical structure could enhance the biological activity and improve the compound characteristics for the development of a product, the present study aimed to verify, if there is the possibility of a significant difference in the bioactivity of verbanol in relation to verbenol. Methods: The biological activity was evaluated by agar diffusion assay and microdilution. Results: Verbanol is a bioactive secondary metabolite produced by the endophytic fungus Diaporthe terebinthifolli LGMF658. This compound has bactericidal activity against Staphylococcus aureus and fungicide against Candida albicans according to the microdilution assay. Discussion: In contrast, verbenol, a byproduct of verbanol, did not control the development of the bacterium and showed fungistatic activity against yeast. Conclusion: The results demonstrated that the presence of the double bond, which increased the polarity of the compound, reduced its bioactivity, corroborating with other studies that report the importance of lipophilicity for antimicrobial action.

Sign in / Sign up

Export Citation Format

Share Document